abiraterone can increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. Consult your physician before adding CBD products.

cannabidiol will increase the level or effect of ambrisentan by affecting hepatic enzyme CYP2C19 metabolism.

amiodarone will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of amiodarone by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of amiodarone by decreasing metabolism. 

amobarbital will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of apalutamide by decreasing metabolism. Modify Therapy/Monitor Closely. Cannabidiol may potentially inhibit CYP2C8 activity. Consider reducing the dose when concomitantly using CYP2C8 substrates.

aprepitant will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

armodafinil will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

atazanavir will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

bicalutamide will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

bortezomib will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of bortezomib by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of bosentan by decreasing metabolism. 

cannabidiol, bupropion. affecting hepatic enzyme CYP2B6 metabolism. 

butabarbital will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

butalbital will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

carbamazepine will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of carisoprodol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of carvedilol by decreasing metabolism. 

cannabidiol will increase the level or effect of celecoxib by decreasing metabolism. 

ceritinib will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

chloramphenicol will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

chloramphenicol will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism.

cannabidiol will increase the level or effect of chlorpropamide by decreasing metabolism.

cannabidiol will increase the level or effect of citalopram by affecting hepatic enzyme CYP2C19 metabolism. 

clarithromycin will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of clobazam by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of clomipramine by affecting hepatic enzyme CYP2C19 metabolism. 

clotrimazole will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

clozapine will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cobicistat will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

conivaptan will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

cannabidiol, conjugated estrogens. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol, conjugated estrogens, vaginal. affecting hepatic enzyme CYP1A2 metabolism.

crizotinib will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol, cyclobenzaprine. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol, cyclophosphamide. affecting hepatic enzyme CYP2B6 metabolism. 

cyclosporine will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

dabrafenib will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of dabrafenib by decreasing metabolism.

cannabidiol, dacarbazine. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol will increase the level or effect of dapsone by decreasing metabolism. 

darunavir will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

cannabidiol will increase the level or effect of dasabuvir by decreasing metabolism. 

delavirdine will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

delavirdine will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

desipramine will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

dexlansoprazole will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C9/10 metabolism. 

cannabidiol will increase the level or effect of dexlansoprazole by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of diazepam by affecting hepatic enzyme CYP2C19 metabolism.

cannabidiol will increase the level or effect of diclofenac by decreasing metabolism. 

diltiazem will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol, doxepin cream. affecting hepatic enzyme CYP1A2 metabolism. 

doxycycline will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

cannabidiol will increase the level or effect of dronabinol by decreasing metabolism. 

dronedarone will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol, duloxetine. affecting hepatic enzyme CYP1A2 metabolism. 

efavirenz will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

efavirenz will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol, efavirenz. affecting hepatic enzyme CYP2B6 metabolism. 

enzalutamide will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

enzalutamide will decrease the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of enzalutamide by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C8 activity. 

erythromycin base will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

erythromycin ethylsuccinate will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

erythromycin lactobionate will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

erythromycin stearate will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of escitalopram by affecting hepatic enzyme CYP2C19 metabolism. 

esketamine intranasal, cannabidiol. Either increases toxicity of the other by sedation. 

eslicarbazepine acetate will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

esomeprazole will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of esomeprazole by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol, estradiol. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol, estrogens conjugated synthetic. affecting hepatic enzyme CYP1A2 metabolism.

etravirine will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

etravirine will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of etravirine by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of etravirine by decreasing metabolism. 

cannabidiol will increase the level or effect of fenofibrate. Cannabidiol may potentially inhibit UGT1A9 activity. 

cannabidiol will increase the level or effect of flibanserin by affecting hepatic enzyme CYP2C19 metabolism. 

fluconazole will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

fluconazole will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

fluoxetine will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of fluoxetine by decreasing metabolism. 

cannabidiol, flutamide. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol will increase the level or effect of fluvastatin by decreasing metabolism. 

fluvoxamine will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

fluvoxamine will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol, fluvoxamine. affecting hepatic enzyme CYP1A2 metabolism.

fosamprenavir will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

fosphenytoin will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of fosphenytoin by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of fosphenytoin by decreasing metabolism. 

fostamatinib will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

gemfibrozil will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of gemfibrozil. Cannabidiol may potentially inhibit UGT2B7 activity. 

cannabidiol will increase the level or effect of glimepiride by decreasing metabolism. 

cannabidiol will increase the level or effect of glipizide by decreasing metabolism. 

cannabidiol will increase the level or effect of glyburide by decreasing metabolism. 

grapefruit will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

haloperidol will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

idelalisib will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of ifosfamide by affecting hepatic enzyme CYP2C19 metabolism. 

iloperidone will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

imatinib will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of imatinib by decreasing metabolism. 

cannabidiol will increase the level or effect of imipramine by affecting hepatic enzyme CYP2C19 metabolism. 

indinavir will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol, irinotecan. affecting hepatic enzyme CYP2B6 metabolism. 

isoniazid will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

isoniazid will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of isotretinoin by decreasing metabolism. 

itraconazole will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of ketamine by decreasing metabolism. 

ketoconazole will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of lacosamide by decreasing metabolism. 

cannabidiol will increase the level or effect of lamotrigine. Cannabidiol may potentially inhibit UGT2B7 activity. 

lansoprazole will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of lansoprazole by affecting hepatic enzyme CYP2C19 metabolism. 

lapatinib will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of lesinurad by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity.

letermovir will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol, lidocaine. affecting hepatic enzyme CYP1A2 metabolism. 

lopinavir will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

loratadine will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism.

cannabidiol will increase the level or effect of lorazepam by decreasing metabolism. Cannabidiol may potentially inhibit UGT2B7 activity. 

cannabidiol will increase the level or effect of losartan by decreasing metabolism. 

lumacaftor/ivacaftor will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

cannabidiol will increase the level or effect of mephobarbital by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will decrease the level or effect of mestranol by decreasing metabolism.

cannabidiol, metaxalone affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol will increase the level or effect of methadone by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C8 activity. 

cannabidiol will increase the level or effect of methsuximide by affecting hepatic enzyme CYP2C19 metabolism. 

metronidazole will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol, mexiletine. affecting hepatic enzyme CYP1A2 metabolism. 

miconazole oral will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of miconazole oral by decreasing metabolism.

mifepristone will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

cannabidiol, mirtazapine. affecting hepatic enzyme CYP1A2 metabolism.

mitotane will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

modafinil will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of modafinil by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of montelukast by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity. 

cannabidiol will increase the level or effect of morphine. Cannabidiol may potentially inhibit UGT2B7 activity. 

nafcillin will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of nateglinide by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity.

nefazodone will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

nelfinavir will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of nelfinavir by affecting hepatic enzyme CYP2C19 metabolism. 

netupitant/palonosetron will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

nevirapine will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

nicardipine will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol, olanzapine. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol will increase the level or effect of ombitasvir/paritaprevir/ritonavir by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C8 activity.

cannabidiol will increase the level or effect of ombitasvir/paritaprevir/ritonavir & dasabuvir by decreasing metabolism. 

omeprazole will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of omeprazole by affecting hepatic enzyme CYP2C19 metabolism. 

osimertinib will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of ospemifene by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of ospemifene by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity. 

oxcarbazepine will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of paclitaxel by decreasing metabolism.

cannabidiol will increase the level or effect of paclitaxel protein bound by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C8 activity.

pantoprazole will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of pantoprazole by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of pentamidine by affecting hepatic enzyme CYP2C19 metabolism. 

pentobarbital will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

phenobarbital will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of phenobarbital by affecting hepatic enzyme CYP2C19 metabolism. 

phenytoin will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of phenytoin by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of phenytoin by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity. 

cannabidiol, pimozide. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol will increase the level or effect of pioglitazone by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C8 activity.

cannabidiol, pirfenidone. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol, pomalidomide. affecting hepatic enzyme CYP1A2 metabolism. 

posaconazole will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of progesterone intravaginal gel by affecting hepatic enzyme CYP2C19 metabolism.

cannabidiol will increase the level or effect of progesterone micronized by affecting hepatic enzyme CYP2C19 metabolism. 

propofol will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of propofol by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity. 

cannabidiol will increase the level or effect of propofol. Cannabidiol may potentially inhibit UGT1A9 activity. 

cannabidiol, propranolol. affecting hepatic enzyme CYP1A2 metabolism. 

quinupristin/dalfopristin will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

rabeprazole will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of rabeprazole by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol, ramelteon. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol, rasagiline. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol will increase the level or effect of repaglinide by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C8 activity. 

ribociclib will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

rifampin will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol, rifampin. affecting hepatic enzyme CYP2B6 metabolism.

rifapentine will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

cannabidiol, riluzole. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol will increase the level or effect of riociguat by decreasing metabolism. 

ritonavir will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol, ropinirole. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol, ropivacaine. affecting hepatic enzyme CYP1A2 metabolism.

cannabidiol will increase the level or effect of rosiglitazone by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C8 activity.

saquinavir will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

schisandra will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

secobarbital will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

cannabidiol, selegiline. affecting hepatic enzyme CYP2B6 metabolism. 

cannabidiol will increase the level or effect of selexipag by decreasing metabolism. 

sertraline will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol will increase the level or effect of sertraline by affecting hepatic enzyme CYP2C19 metabolism.

St John’s Wort will decrease the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

cannabidiol will increase the level or effect of sulfadiazine by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity. 

cannabidiol will increase the level or effect of sulfisoxazole by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity. 

cannabidiol, tacrine. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol will increase the level or effect of tamoxifen by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity. 

cannabidiol, tasimelteon. affecting hepatic enzyme CYP1A2 metabolism. 

tetracycline will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol, theophylline. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol, thiothixene. affecting hepatic enzyme CYP1A2 metabolism.

ticlopidine will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

tipranavir will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

cannabidiol, tizanidine. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol will increase the level or effect of tofacitinib by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of tolbutamide by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity.

cannabidiol will increase the level or effect of torsemide by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity. 

tranylcypromine will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of treprostinil by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C8 activity.

cannabidiol will increase the level or effect of tretinoin by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C8 activity.

cannabidiol, trifluoperazine. affecting hepatic enzyme CYP1A2 metabolism.

cannabidiol will increase the level or effect of trimethoprim by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity.

cannabidiol will increase the level or effect of trimipramine by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol, velpatasvir. affecting hepatic enzyme CYP2B6 metabolism. 

cannabidiol will increase the level or effect of velpatasvir by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C8 activity. 

verapamil will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

voriconazole will increase the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 

voriconazole will increase the level or effect of cannabidiol by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of voriconazole by affecting hepatic enzyme CYP2C19 metabolism. 

cannabidiol will increase the level or effect of voriconazole by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity. 

cannabidiol, voxilaprevir. affecting hepatic enzyme CYP1A2 metabolism. 

cannabidiol will increase the level or effect of voxilaprevir by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C8 activity. 

cannabidiol will increase the level or effect of warfarin by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity. 

cannabidiol will increase the level or effect of zafirlukast by decreasing metabolism. Cannabidiol may potentially inhibit CYP2C9 activity.